Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-19
DOI
10.1038/s41409-021-01308-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
- (2020) Michele Cavo et al. Lancet Haematology
- Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
- (2019) Joseph Mikhael et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017
- (2019) Patrick J Hayden et al. BLOOD
- Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma
- (2018) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma
- (2018) Aaron S Rosenberg et al. JNCI-Journal of the National Cancer Institute
- Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
- (2018) Morie A. Gertz et al. MAYO CLINIC PROCEEDINGS
- Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma
- (2018) Aaron S Rosenberg et al. JNCI-Journal of the National Cancer Institute
- Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma
- (2018) Carolina Marini et al. ANNALS OF HEMATOLOGY
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Immunotherapies for Multiple Myeloma
- (2017) Mattia D’Agostino et al. Current Hematologic Malignancy Reports
- Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
- (2017) Nikhil C. Munshi et al. JAMA Oncology
- Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study
- (2016) Yael C Cohen et al. ANNALS OF HEMATOLOGY
- A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013
- (2016) Ian Nivison-Smith et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
- (2016) Krystal Bergin et al. BMC Medical Research Methodology
- Autologous stem cell transplant for multiple myeloma patients 70 years or older
- (2016) E Muchtar et al. BONE MARROW TRANSPLANTATION
- Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
- (2016) Laurent Garderet et al. HAEMATOLOGICA
- Novel agents in the treatment of multiple myeloma: a review about the future
- (2016) Leonard Naymagon et al. Journal of Hematology & Oncology
- A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
- (2016) S Hipp et al. LEUKEMIA
- Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
- (2016) Laurent Garderet et al. HAEMATOLOGICA
- Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma
- (2015) Luciano J. Costa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results–Medicare Database
- (2015) Gunjan L. Shah et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
- (2015) A. Palumbo et al. BLOOD
- Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma
- (2015) Jianxuan Zou et al. CANCER SCIENCE
- Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
- (2015) H. Quach et al. INTERNAL MEDICINE JOURNAL
- The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma
- (2015) Aaron N. Winn et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
- (2015) Francesca Gay et al. LANCET ONCOLOGY
- The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma
- (2015) Aaron N. Winn et al. JNCI-Journal of the National Cancer Institute
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
- (2014) Manish Sharma et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
- (2014) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- All transplantation-eligible patients with myeloma should receive ASCT in first response
- (2014) P. Moreau et al. Hematology-American Society of Hematology Education Program
- Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
- (2013) M. Merz et al. ANNALS OF ONCOLOGY
- Low Uptake of Upfront Autologous Transplantation for Myeloma in a Jurisdiction With Universal Health Care Coverage: A Population-Based Patterns of Care Study in Australia
- (2013) Nicole Wong Doo et al. Clinical Lymphoma Myeloma & Leukemia
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma
- (2013) Ian Nivison-Smith et al. LEUKEMIA & LYMPHOMA
- Proteasome inhibitors in multiple myeloma: 10 years later
- (2012) P. Moreau et al. BLOOD
- Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients
- (2011) Hakan Kaya et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure
- (2009) Andrew Spencer et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started